Lilly Just Announced Infectious Disease Deals Diversification
Eli Lilly is shaking up its growth plan by expanding beyond obesity with new infectious disease initiatives. This art...
Track changes in personal budgets to understand drivers, uncover trends, and refine spending and saving habits.
22,888 articlesEli Lilly is shaking up its growth plan by expanding beyond obesity with new infectious disease initiatives. This art...
A flurry of news sent Kymera Therapeutics stock popping this week. From trial milestones to new price targets and ins...
Intuit has fallen hard this year, but a big drawdown can create a patient entry point. This guide breaks down the bus...
AST SpaceMobile faced a sharp weekly drop after announcing a large convertible debt raise. This article explains why ...
A rising institutional move shines a light on how large managers deploy capital in broad market ETFs. This piece brea...
Block pivots on AI, slashing 40% of jobs as it refocuses on crypto tools and fintech services. This morning minute lo...
You don't need to chase risky bets to beat the market. With $3,000, you can target the smartest growth stock with dur...
Leveraged ETFs like TQQQ and QLD promise amplified Nasdaq-100 exposure, but they come with unique risks and timing re...
LifeStance Health Group stunned the market with a beat-and-raise quarter, sending its stock up roughly 20%. This deep...
A sharp one-day drop in ZoomInfo’s shares has investors weighing growth against profitability. This analysis explains...
A new AI chip contender is entering the arena. This guide examines whether could cerebras next nvidia? is a realistic...
Oil prices rose and energy stocks jumped after the tensions since iran began. This guide breaks down whether it’s sti...